Advanced search
Publication Cover
Annals of Tropical Paediatrics
International Child Health
Volume 21, 2001 - Issue 3
Journal homepage
5
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Haemophilus influenza type b vaccine in Israel: experience in a paediatric ambulatory clinic

Tsivia TauberPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
,
Eliezer LahatPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
,
Galit DounskyPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
,
Julio KarpuchPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
,
Yael FrenkelPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
,
Amir LivnePaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
&
Matitiahu BerkovitchPaediatric Ambulatory Clinic, Assaf Harofeh Medical Centre, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Zerifin, IsraelCorrespondence[email protected]
 show all
Pages 231-234 | Accepted 01 May 2001, Published online: 13 Jul 2016

References

  • Halfon-Yaniv I, Dagan R. Epidemiology of invasive Haemophilus influenza type b infections in Bedouins and Jews in southern Israel. Pediatr Infect Dis J 1990; 9: 321–6.
  • Dagan R. Epidemiology of invasive Haemophilus influenza type b (Hib) disease in Israel. Vaccine 1993; 1 1(suppl.1): 43–5.
  • Greenberg DP, Vadheim CM, Bordenave N, et al. Protective efficacy of Haemophilus influenza type b polysaccharide and conjugate vaccines in children 18 months of age and older. JAMA 1991; 265: 987–92.
  • Murphy TV, White KE, Pastor P, et al. Declining incidence of Haemophilus influenza type b disease since introduction of vaccination. JAMA 1993; 269: 246–8.
  • Centers for Disease Control and Prevention. Leads from the Morbidity and Mortality Weekly Report. Progress toward elimination of Haemophilus influenza type b disease among infants and children—United States, 1987–1993. JAMA 1994; 271: 1231–2.
  • The Israel Centre for Disease Control. Notifiable infectious diseases in Israel 1951–1995. Epidemiology Department, Public Health Services, Israel Ministry of Health. Publication no. 201, September 1996, p61.
  • Department of Epidemiology, Israel Ministry of Health. Annual Report, September 2000.
  • Vadheim CM, Greenberg DP, Eriksen E, et al. Eradication of Haemophilus influenza type b disease in Southern California. Arch Pediatr Adolesc Med 1994; 148: 51–6.
  • Peltola H, Kayhty H, Virtanen M, Makela PH. Prevention of Haemophilus influenza type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med 1984; 310: 1561–6.
  • Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenza type b conjugate vaccine PRP-T. Lancet 1994; 344: 362–6.
  • Vadheim CM, Greenberg DP, Eriksen E, et al. Protection provided by Haemophilus influenza type b conjugate vaccines in Los Angeles County: a case control study. Pediatr Infect Dis J 1994; 13: 274–80.
  • Harrison LH, Tajkowski C, Croll J, et al. Postlicensure effectiveness of the Haemophilus influenza type b polysaccharide-Neisseria meningitides outer-membrane protein complex conjugate vaccine among Navajo children. J Pediatr 1994; 125: 571–6.
  • Hiner EE, Frasch C. Spectrum of diseases due to Haemophilus influenza type b occurring in vaccinated children. J Infect Dis 1988; 158: 343–8.
  • Loughlin AM, Marchant CD, Lett S, Shapiro ED. Efficacy of Haemophilus influenza type b vaccines in Massachusetts children 18 to 59 months of age. Pediatr Infect Dis J 1992; 11: 372–9.
  • Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenza type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221–6.
  • Heath PT. Haemophilus influenza type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998; 17(suppl.9): 117–22.
  • Booy R, Health PT, Slack MP, Begg N, Moxon ER. Vaccine failures after primary immunisation with Haemophilus influenza type-b conjugate vaccine without booster. Lancet 1997; 349: 1197–202.
  • Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenza type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191–7.
  • Muhlemann K, Alexander ER, Weiss NS, Pepe M, Schopfer K. Risk factors for invasive Haemophilus influenza disease among children 2–16 years of age in the vaccine era. Int J Epidemiol 1996; 25: 1280–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.